Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
PBM reform unlikely to attach to short-term spending bill as shutdown looms
5 months ago
Pharma
FDA+
Accelerated approval brings Pfizer's BRAF inhibitor to first-line patients
5 months ago
Pharma
FDA+
Califf, on his way out at FDA, predicts agency tug-of-war between Ramaswamy and RFK Jr.
5 months ago
FDA+
Rhythm receives expanded approval for genetic obesity drug
5 months ago
Pharma
FDA+
FDA approves Humacyte’s lab-grown blood vessels in milestone for regenerative medicine
5 months ago
R&D
FDA+
GSK's Zejula-Jemperli combo in ovarian cancer hits primary endpoint, misses on overall survival
5 months ago
R&D
Sofinnova outlines $550M fund after IPOs and M&A deals
5 months ago
Financing
Startups
Applied Therapeutics CEO steps down after rare disease drug rejection
5 months ago
People
FDA+
Idorsia’s Tryvio deal delay; Galectin’s liver drug disappoints
5 months ago
News Briefing
Commure's latest acquisition sends follow-up texts to patients
5 months ago
Deals
Health Tech
Tracer Biotechnologies raises $10M, partners with AstraZeneca
5 months ago
Deals
Diagnostics
Daiichi Sankyo finds successor to late R&D exec; Versant, Novartis' kidney biotech poaches Sana CBO
5 months ago
Peer Review
Aadi starts from scratch as it sells assets, licenses ADCs and raises new funds
5 months ago
Deals
R&D
Exclusive: Florida cancer biotech raises $100M Series A
5 months ago
Financing
Startups
Updated: Novo’s 23% weight loss with CagriSema falls short of high expectations, new trial planned
5 months ago
R&D
FDA approves Ionis’ treatment for a rare metabolic disorder
5 months ago
FDA+
FDA rejects Zealand Pharma's short bowel syndrome drug
5 months ago
FDA+
Xcovery nabs first FDA approval for lung cancer drug
5 months ago
Pharma
FDA+
Mesoblast wins long-awaited approval for cell therapy
5 months ago
Pharma
Cell/Gene Tx
Payers generally meet drug price watchdog's 'fair access' standards, report says
5 months ago
Pharma
FDA+
Regeneron forges ahead in factor XI despite field’s mixed results
5 months ago
R&D
Pharma
What health tech startups can expect in 2025
5 months ago
Health Tech
Gilead deepens its stake in Assembly Biosciences; NGM licenses out MASH drug
5 months ago
News Briefing
In blow to compounders, FDA reaffirms tirzepatide shortage is over
5 months ago
Pharma
Health Tech
First page
Previous page
61
62
63
64
65
66
67
Next page
Last page